73
Views
12
CrossRef citations to date
0
Altmetric
Adenomyosis

Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis

, , , &
Pages 127-131 | Published online: 07 Jul 2009

References

  • Leyendecker G, Herbertz M, Kunz G, Mall G. Endometriosis results from dislocation of basal endometrium. Hum Reprod 2002;17:2725–2736.
  • Yananoto T, Noguchi T, Tamura T, Kitawaki J, Okada H. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 1993;169:734–738.
  • Mertens HJ, Heineman MJ, Evers JL. The expression of apoptosis-related proteins Bc1-2 and Ki-67 in endometrium of ovulatory menstrual cycle. Gynecol Obstet Invest 2002;53: 375–382.
  • Fedele L, Bianchi S, Raffaeli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426–429.
  • Maia H Jr, Maltez A, Coelho G, Athayde C, Coutinho EM. Insertion of Mirena® after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003;10:512–516.
  • Maruo T, Laog-Fernandez P, Pakarinen P, Murakoshi H, Spitz IM, Johanson E. Effects of levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod 2001;16:2103–2108.
  • Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F. Apoptosis in human endometrial and endometriotic tissues. Horm Res 1997;48(Suppl 3):42–47.
  • Zhang L, Li J, Li M. Expression of bc1-2 protein in adenomyosis. Zhonghua Fu Chan Ke Za Zhi 2000;35: 533–535.
  • Huang F, Lin QH, Liu FY, Zhong ZS. Expression of bc1-2 in normal endometrium and endometrium of adenomyosis. Human Yi Ke Da Xue Xue Bao 2000;25:453–456.
  • Matsumoto Y, Iwasaka T, Yamasaki F, Sugimori H. Apoptosis and Ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999;94:71–77.
  • Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T. Apoptosis, proliferation, and sex hormone receptors in super-ficial parts of human endometrium at the end of secretory phase. J Chin Endocrinol Metab 1999;84:1737–1743.
  • Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intra-uterine system. Contraception 1999;60:173–176.
  • von Rango U, Classen-Linke I, Krusche CA, Beier HM. The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 1998;13:3177–3189.
  • Ikomi A, Pepra EF. Efficacy of levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities. J Farn Plann Reprod Health Care 2002;28:99–100.
  • Goswami A, Khemani M, Logani KB, Amand R. Adeno-myosis: diagnosis by hysteroscopic endo-myometrial biopsy; correlation of incidence and severity with menorrhagia. J Obstet Gynaecol Res 1998;24:281–291.
  • Falk RJ, Mullin BR. Exacerbation of adenomyosis sympto-matology by estrogen-progestin therapy: a case report and histopathological observations. Int J Fertil 1989;34:386–389.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.